Oligonucleotide Symposium: Solutions to Analytical Challenges, CMC Factors, and Compliance Considerations in Biopharmaceutical Manufacturing

Therapeutic oligonucleotides (oligos) have emerged as an area of particular interest and promise in biopharmaceutical research because of their potential to treat a wide range of disease.
 
This half-day symposium will take you on a journey through the world of oligonucleotides. Beginning at preparation and manufacture, then on to analytical method development and optimization, before ending with regulatory and compliance considerations; our three experts will cover everything you need to know about these exciting, yet complex molecules. 

Topics include:

• Oligonucleotide Analysis in Biopharma Manufacturing: Method Development when Scaling up to Prep
• Oligo Analytical Method Development Optimization to Species
• Oligo/Nucleic Acid Regulatory and Compliance Considerations